Yes, Mounjaro (tirzepatide) is covered by Medicare for type 2 diabetes, but only through plans that include prescription drug benefits. If you have a Medicare Part D plan or a Medicare Advantage plan with drug coverage, Mounjaro can be covered when prescribed to manage type 2 diabetes. However, most plans require prior authorization and proof that you’ve tried other diabetes medications first.
Which Parts of Medicare Cover Mounjaro
Mounjaro is a self-injected medication you use at home, so it falls under Medicare Part D (prescription drug coverage) rather than Part B (which covers drugs administered in a doctor’s office). If you have Original Medicare without a standalone Part D plan, you won’t have coverage for Mounjaro. You need either a Part D plan or a Medicare Advantage (Part C) plan that includes prescription drug benefits.
Not every Part D or Advantage plan includes Mounjaro on its formulary. Each plan maintains its own drug list, and coverage, tier placement, and costs vary by plan and state. Before starting Mounjaro, check your specific plan’s formulary or call the number on your membership card to confirm it’s covered.
Prior Authorization and Step Therapy
Even when Mounjaro is on your plan’s formulary, you’ll almost certainly need prior authorization before the pharmacy will fill it. This means your doctor submits documentation to your plan showing that the prescription meets specific criteria. For most plans, the key requirements are straightforward: you must be 18 or older and have a diagnosis of type 2 diabetes.
Many Medicare plans also require step therapy, meaning you need to have tried at least one other oral diabetes medication before Mounjaro will be approved. Some plans have automated systems that check your recent prescription history. If you’ve filled a claim for an oral diabetes medication within the past 130 days, approval can process automatically without extra paperwork from your doctor. If you’re new to diabetes treatment or haven’t recently used another medication, your doctor may need to document your treatment history more explicitly.
Once approved, authorization typically lasts one year before needing renewal.
What You’ll Pay Out of Pocket
On most Medicare Part D formularies, Mounjaro is placed on Tier 3, which is a preferred brand-name tier. The coinsurance percentage for Tier 3 varies by plan, but many charge around 25% of the drug’s cost until you hit your annual spending limit.
Here’s where the Inflation Reduction Act makes a real difference. Starting in 2025, Medicare Part D has a hard cap of $2,000 per year on out-of-pocket drug spending. Once you’ve paid $2,000 total across all your prescriptions in a calendar year, you pay nothing more for covered drugs for the rest of that year. Since Mounjaro’s retail price is over $1,000 per month, you could hit that cap within the first few months of the year, meaning the rest of your fills would cost you $0. Many Part D plans also let you spread that $2,000 across monthly payments rather than paying it all upfront.
Coverage for Weight Loss Is Different
This is where things get important: Medicare covers Mounjaro only for type 2 diabetes. It does not cover Mounjaro for weight loss alone. The same active ingredient (tirzepatide) is sold under a different brand name, Zepbound, for weight management. Historically, Medicare has been prohibited by law from covering drugs prescribed solely for weight loss.
That’s changing partially in 2026. Starting July 1, 2026, a new program called the Medicare GLP-1 Bridge will provide coverage for certain weight loss medications, including Zepbound and Wegovy, specifically for reducing excess body weight. But this bridge program operates outside of the normal Part D benefit, and it won’t affect how Mounjaro itself is covered. If your doctor prescribes Mounjaro, the prescription needs to be for type 2 diabetes management.
If your doctor prescribes Zepbound for a condition that Part D already covers (like obstructive sleep apnea in adults with obesity), that would go through your Part D plan’s normal process rather than the bridge program. The distinctions between brand names and indications matter here, so make sure your prescription reflects the correct diagnosis.
How to Check Your Specific Coverage
Because formularies differ across plans, the most reliable way to confirm your coverage is to look up Mounjaro on your plan’s drug list. You can do this by logging into your plan’s member portal, calling your plan’s pharmacy helpline, or using Medicare’s plan finder tool at Medicare.gov. When you check, pay attention to three things: whether Mounjaro is listed, what tier it’s on, and what utilization management requirements apply (prior authorization, step therapy, or quantity limits).
If Mounjaro isn’t on your plan’s formulary, you have options. Your doctor can request a formulary exception, arguing that Mounjaro is medically necessary for you. You can also switch plans during the annual enrollment period (October 15 through December 7) to one that includes Mounjaro. If you’re comparing plans, look specifically at the tier placement and any restrictions, since a plan that lists Mounjaro on a lower tier could save you hundreds of dollars over the year, even with the $2,000 cap in place.